Geneva Advisors’s ECA Marcellus Trust 1 Interest ECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$105K Buy
50,000
+20,000
+67% +$41.9K ﹤0.01% 700
2017
Q1
$65K Hold
30,000
﹤0.01% 724
2016
Q4
$65K Hold
30,000
﹤0.01% 731
2016
Q3
$66K Hold
30,000
﹤0.01% 707
2016
Q2
$60K Hold
30,000
﹤0.01% 665
2016
Q1
$44K Hold
30,000
﹤0.01% 666
2015
Q4
$45K Hold
30,000
﹤0.01% 626
2015
Q3
$51K Hold
30,000
﹤0.01% 593
2015
Q2
$86K Buy
30,000
+20,000
+200% +$71.4K ﹤0.01% 638
2015
Q1
$38K Sell
10,000
-600
-6% -$2.22K ﹤0.01% 651
2014
Q4
$33K Sell
10,600
-1,600
-13% -$7.14K ﹤0.01% 668
2014
Q3
$67K Buy
+12,200
New +$81.8K ﹤0.01% 641

Other funds holding ECT

Geneva Advisors's ECT Position: Q2 2017 in Review

Geneva Advisors increased its ECA Marcellus Trust 1 Interest (ECT) stake by 67% in Q2 2017, buying an estimated $41.9K and bringing the position to 50,000 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Geneva Advisors first reported a position in ECT in Q3 2014 and has held it in 12 quarters since. 27 funds tracked by Wall St. Rank hold ECT as of Q2 2017.

  • Geneva Advisors held 50,000 shares of ECA Marcellus Trust 1 Interest worth $105K as of Q2 2017.
  • Geneva Advisors bought 20,000 ECA Marcellus Trust 1 Interest shares in Q2 2017, an estimated $41.9K.
  • ECA Marcellus Trust 1 Interest made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #700 holding.
  • Geneva Advisors first reported a position in ECA Marcellus Trust 1 Interest in Q3 2014 and has held it in 12 quarters since.
  • 27 funds tracked by Wall St. Rank held ECA Marcellus Trust 1 Interest as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.